Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Univl Health Services (NY:UHS)

155.60 +0.14 (+0.09%)
Official Closing Price Updated: 7:00 PM EDT, Jul 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Univl Health Services

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
NYSE:UHS: good value for what you're paying.
Don't overlook UNIVERSAL HEALTH SERVICES-B (NYSE:UHS)—it's a hidden gem with strong fundamentals and an attractive price tag. 
Via Chartmill
$1000 Invested In Universal Health Servs 20 Years Ago Would Be Worth This Much Today
 
Via Benzinga
NYSE:UHS appears to be flying under the radar despite its strong fundamentals.
Investors should take notice ofUNIVERSAL HEALTH SERVICES-B (NYSE:UHS)—it offers a great deal for the fundamentals it presents. 
Via Chartmill
$1000 Invested In This Stock 20 Years Ago Would Be Worth $8,700 Today
 
Via Benzinga
Decoding 12 Analyst Evaluations For Universal Health Servs
 
Via Benzinga
Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Mining
Darwin Financial's Joshua Robinson talks to Benzinga about the firm's latest commodities deal, and more M&A news from this past week. 
Via Benzinga
(UHS) - Analyzing Universal Health Servs's Short Interest
 
Via Benzinga
NYSE:UHS: good value for what you're paying.
Despite its impressive fundamentals, UNIVERSAL HEALTH SERVICES-B (NYSE:UHS) remains undervalued. 
Via Chartmill
For those who appreciate value investing, NYSE:UHS is a compelling option with its solid fundamentals.
UNIVERSAL HEALTH SERVICES-B (NYSE:UHS) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. 
Via Chartmill
Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga's Deal Dispatch has the latest M&A updates. 
Via Benzinga
Golden Years For M&A Deals Ahead Under Trump? Analysts Highlight Top 10 Large-Cap Candidates
GOP control of Congress under Trump could lead to a surge in M&A activity, especially in banks and biotech. Factors like equity market returns and rate cuts could fuel deals, with small-cap targets and... 
Via Benzinga
Topics Government
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $9,700 Today
 
Via Benzinga
Looking Into Universal Health Servs's Recent Short Interest
 
Via Benzinga
Assessing Universal Health Servs: Insights From 16 Financial Analysts
 
Via Benzinga
S&P 500, Dow Hit Record Highs After Trump Win; Fear Index Drops 20%
Market surges to record highs after Trump's election, Republicans win Senate majority. Tech and small-caps up, VIX drops 22%. 
Via Benzinga
Topics Government Stocks
HCA Healthcare: Temporary Setbacks, Long-Term Strength
HCA Healthcare is one of the nations biggest hospital companies. Despite recent hurricane impacts tis company remains well positioned long term. 
Via MarketBeat
Genuine Parts Company, Universal Health Services, And TopBuild Are Among Top 10 Large Cap Losers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?
Ten large-cap stocks: ICON, Genuine Parts, Newmont, Tenet Healthcare, Universal Health, HCA Healthcare, TopBuild, Carlisle, Teradyne, Comfort Systems. 
Via Benzinga
$1000 Invested In Universal Health Servs 15 Years Ago Would Be Worth This Much Today
 
Via Benzinga
NYSE:UHS is probably undervalued for the fundamentals it is displaying.
UNIVERSAL HEALTH SERVICES-B (NYSE:UHS) appears to be flying under the radar despite its strong fundamentals. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Critical Insights From Universal Health Servs Analyst Ratings: What You Need To Know
 
Via Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, Oct. 19
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Oct. 14-18, 2024. 
Via Talk Markets
Hurricane Milton Descends On Florida: Analysts Warn Of Impact On Disney, NextEra's Florida Power & Light, Regional Banks
Analysts weigh in on Hurricane Milton's negative impact on different sectors and whether there could be buying opportunities for the long term. 
Via Benzinga
Analyst Expectations For Universal Health Servs's Future
 
Via Benzinga
What 16 Analyst Ratings Have To Say About Universal Health Servs
 
Via Benzinga
3 Hospital Stocks To Buy With Strong Earnings Estimate Revisions
The U.S. hospital industry has been in good health over the past year. At this stage, investment in hospital stocks could be prudent in the near-term. Here are 3 such stocks that may be worth... 
Via Talk Markets
Investors should take notice of NYSE:UHS—it offers a great deal for the fundamentals it presents.
For those who appreciate value investing, UNIVERSAL HEALTH SERVICES-B (NYSE:UHS) is a compelling option with its solid fundamentals. 
Via Chartmill
Green Day Has The Right Idea As September Seasonality Comes In Hot
In this video, I analyze our current market condition and leading ETFs as we move through September's historically weak seasonality. 
Via Talk Markets
Topics ETFs
IBD Stock Of The Day: IPO In Red-Hot Industry Group Flashes Buy Signal
Ardent Health is in Medical-Hospitals, ranked 10th out of 197 industries. 
Via Investor's Business Daily
Topics Initial Public Offering
NYSE:UHS appears to be flying under the radar despite its strong fundamentals.
When you look at UNIVERSAL HEALTH SERVICES-B (NYSE:UHS), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.